LifeTech Scientific Corp
HKEX:1302
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
LifeTech Scientific Corp
HKEX:1302
|
CN |
|
Tod's SpA
MIL:TOD
|
IT |
|
Carlisle Companies Inc
NYSE:CSL
|
US |
|
Minor International PCL
OTC:MNILY
|
TH |
|
B
|
Bright Outdoor Media Ltd
BSE:543831
|
IN |
|
Lords Chloro Alkali Ltd
BSE:500284
|
IN |
|
C
|
Cameco Corp
NYSE:CCJ
|
CA |
|
NFI Group Inc
TSX:NFI
|
CA |
|
S
|
Shufersal Ltd
TASE:SAE
|
IL |
|
Red Electrica Corporacion SA
LSE:0RI5
|
ES |
|
T
|
Tarc Ltd
NSE:TARC
|
IN |
|
Align Technology Inc
NASDAQ:ALGN
|
US |
|
Nektar Therapeutics
NASDAQ:NKTR
|
US |
|
Z
|
Zhejiang Yankon Group Co Ltd
SSE:600261
|
CN |
|
Stellantis NV
MIL:STLAM
|
NL |
|
Z
|
Zen Technologies Ltd
NSE:ZENTEC
|
IN |
|
Roblox Corp
NYSE:RBLX
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Proximus NV
OTC:BGAOF
|
BE |
|
F
|
Fortune Brands Home & Security Inc
LSE:0IRN
|
US |
LifeTech Scientific Corp
LifeTech Scientific Corp. is an investment holding company, which engages in the development, manufacture, research, development and market of minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders. The company is headquartered in Shenzhen, Guangdong and currently employs 943 full-time employees. The company went IPO on 2011-11-10. The firm operates through three business segments. The Congenital Heart Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to congenital and structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to peripheral vascular diseases. The Surgical Vascular Repair Business segment is engaged in the research and development, manufacture and trading of devices related to surgical vascular repair.
LifeTech Scientific Corp. is an investment holding company, which engages in the development, manufacture, research, development and market of minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders. The company is headquartered in Shenzhen, Guangdong and currently employs 943 full-time employees. The company went IPO on 2011-11-10. The firm operates through three business segments. The Congenital Heart Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to congenital and structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to peripheral vascular diseases. The Surgical Vascular Repair Business segment is engaged in the research and development, manufacture and trading of devices related to surgical vascular repair.
